PAK 200
Alternative Names: PAK 200SLatest Information Update: 31 Jan 2008
At a glance
- Originator Nissan Chemical Industries
- Class Antineoplastics; Dihydropyridines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Reperfusion injury